Glycans â€“ the third revolution in evolution by Gordan Lauc et al.
PERSPECTIVE ARTICLE
published: 23 May 2014
doi: 10.3389/fgene.2014.00145
Glycans – the third revolution in evolution
Gordan Lauc1,2*, Jasminka Krištic´ 2 andVlatka Zoldoš3
1 Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
2 Genos Glycoscience, Zagreb, Croatia
3 Department of Molecular Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia
Edited by:
Jose M. Eirin-Lopez, Florida
International University, USA
Reviewed by:
Jose Ignacio Jimenez, University of
Surrey, UK
Rodrigo Gonzalez-Romero, University
of Victoria, Canada
*Correspondence:
Gordan Lauc, Department of
Biochemistry and Molecular Biology,
Faculty of Pharmacy and
Biochemistry, University of Zagreb,
A. Kovacˇic´a 1, 10000 Zagreb, Croatia
e-mail: glauc@pharma.hr
The development and maintenance of a complex organism composed of trillions of cells
is an extremely complex task. At the molecular level every process requires a speciﬁc
molecular structures to perform it, thus it is difﬁcult to imagine how less than tenfold
increase in the number of genes between simple bacteria and higher eukaryotes enabled
this quantum leap in complexity. In this perspective article we present the hypothesis that
the invention of glycanswas the third revolution in evolution (the appearance of nucleic acids
and proteins being the ﬁrst two), which enabled the creation of novel molecular entities that
do not require a direct genetic template. Contrary to proteins and nucleic acids, which are
made from a direct DNA template, glycans are product of a complex biosynthetic pathway
affected by hundreds of genetic and environmental factors. Therefore glycans enable
adaptive response to environmental changes and, unlike other epiproteomic modiﬁcations,
which act as off/on switches, glycosylation signiﬁcantly contributes to protein structure
and enables novel functions. The importance of glycosylation is evident from the fact that
nearly all proteins invented after the appearance of multicellular life are composed of both
polypeptide and glycan parts.
Keywords: glycosylation, evolution, genetics, epigenetics
GLYCANS ARE ONE OF FOUR MAJOR GROUPS OF
MACROMOLECULES
Carbohydrates are one of fourmajor groups of biologically impor-
tant macromolecules that can be found in all forms of life. They
have many biochemical, structural, and functional features that
could provide a number of evolutionary beneﬁts or even stimulate
or enhance some evolutionary events. During evolution, carbohy-
drates served as a source of food and energy, provided protection
against UV radiation and oxygen free radicals and participated
in molecular structure of complex organisms. With time, sim-
ple carbohydrates became more complex through the process of
polymerization and evolved novel functions. According to the one
origin of life theory, called glyco-world, carbohydrates are thought
to be the original molecules of life, which provided molecular
basis for the evolution of all living things (Stern and Jedrzejas,
2008). Ribose and deoxyribose are integral parts of RNA and
DNA molecules and cellulose (glucose polymer) is the most abun-
dant molecule on the planet. There is also evidence for catalytic
properties of some carbohydrates (Del Valle, 2004) which further
support theory about the capacity of glycans to enable evolution
of life.
Carbohydrates are essential for all forms of life, but the largest
variety of their functions is now found in higher eukaryotes. The
majority of eukaryotic proteins are modiﬁed by cotranslational
and posttranslational attachment of complex oligosaccharides
(glycans) to generate the most complex epiproteomic modiﬁca-
tion – protein glycosylation.Very large number of different glycans
can be made by varying number, order and type of monosac-
charide units. The most abundant monosaccharides that can be
found in animal glycan are: fucose (Fuc), galactose (Gal), glucose
(Glu), mannose (Man), N-acetylgalactosamine (GalNAc), N-
acetylglucosamine (GlcNAc), sialic acid (Sia) and xylose (Xyl).
There are two main ways for protein modiﬁcation with glycans:
O-glycosylation and N-glycosylation. In O-glycosylation, the gly-
can is bound to the oxygen (O) atom of serine or threonine amino
acid in the protein. Another type of protein glycosylation is N-
glycosylation, where glycan is bound to the nitrogen (N) atom of
asparagine amino acid in the protein.
Surfaces of all eukaryotic cells are covered with a thick layer
of complex glycans attached to proteins or lipids. Many cells in
our organism can function without the nuclei, but there is no
known living cell that can function without glycans on their sur-
face. Anything approaching the cell, being it a protein, another cell,
or a microorganism, has to interact with the cellular glycan coat
(Gagneux and Varki, 1999; Varki and Lowe, 2009; Varki, 2011).
This appears to be a universal rule since even in sponges, which
are the simplest multicellular organisms formed by more or less
independent cells, the recognition between cells is based on gly-
cans (Misevic and Burger, 1993). One of the critical steps in the
evolution of multicellularity was formation of extracellular matrix
(ECM; Sachs, 2008; Hynes, 2012). Multicellular life evolved inde-
pendently multiple times during evolution and there are two main
theories how the initial multicellular group of cells was made.
The ﬁrst theory says that individual cell came together to create
symbiotic colonies, and another theory is that cells stayed together
after cell division (Sachs,2008). Appearance of extracellularmatrix
enabled this initial group of cells to start function as a coordinated
unit. Extracellular matrix has huge importance for multicellular
organisms (Hynes, 2009). It has role in cell signaling, commu-
nication between cells, cell adhesion and in transmitting signal
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from the environment, and also provides structural support for
cells, tissues and organs. Extracellular matrix plays essential role
in numerous fundamental processes such as differentiation, prolif-
eration, survival and migration of cells. The main components of
ECM are glycoproteins and proteoglycans and the same molecules
are responsible for functional properties of ECM(Hynes andNaba,
2012). Extracellular matrix evolved in parallel with ﬁrst multicel-
lular organisms (Hynes, 2012), therefore, glycans of the early ECM
probably participated in evolution of multicellular organisms by
enabling communication between cells and thus provided signals
for cooperation and differentiation.
In addition to ECM, glycans also provide other proper-
ties and functions important for development of multicellular
organisms. For example, in some fungal species the sugar
N-acetylglucosamine (GlcNAc) acts as a signal that stimulates
unicellular fungi to start to grow in a multicellular ﬁlamentous
form (Simonetti et al., 1974; Naseem et al., 2012). The same sugar
modiﬁes proteins in multicellular organisms and some of these
modiﬁcations represent an important mechanism for the regu-
lation of signaling, for example signaling through Notch protein
(Rana and Haltiwanger, 2011).
GLYCANS PERFORM NUMEROUS FUNCTIONS IN COMPLEX
ORGANISMS
In complex organisms like humans, glycans play an important
role in virtually all processes that involve more than one cell (Walt
et al., 2012). Nearly all membrane and secreted proteins are modi-
ﬁed by covalent addition of glycans with very high site occupancy
(Zielinska et al., 2010). Absence of glycosylation is embryonically
lethal (Marek et al., 1999) and mutations which obstruct proper
glycosylation cause debilitating diseases (Freeze, 2006). This is not
surprising since glycan parts of (glyco) proteins are integral ele-
ments of the ﬁnal molecular structure and together with amino
acids in the polypeptide backbone they form a single molecu-
lar entity that performs biological functions. Contrary to other
posttranslational modiﬁcations that generally function as on/off
switches, glycosylation generates large complex structures with
more profound functions. The role of glycans in biological pro-
cess should not be ignored since large part of the picture is missing
when proteins are being studied without its glycans, or with wrong
glycans attached during production of recombinant proteins in
non-native organisms, cell types or cellular environment. Unfor-
tunately this is often being done and consequently we are missing
essential biological information for many physiological processes.
Two large obstacles in the study of glycans are their non-linear
complex chemical structure and the absence of a direct genetic
template. Contrary to polypeptides, which are a direct transla-
tion of the corresponding gene, glycans are encoded in a complex
dynamic network comprising hundreds of genes (Nairn et al.,
2008; Lauc et al., 2010). In addition to variation in nucleotide
sequence of all genes in this complex biosynthetic pathway, numer-
ous past and present environmental factors also affect the ﬁnal
outcome (Kneževic´ et al., 2010; Lauc and Zoldoš, 2010). However,
despite the absence of a direct genetic template, heritability of gly-
come composition was reported to be high (Kneževic´ et al., 2009;
Pucic et al., 2011), even over 80% for some of the glycans in the
IgG glycome (Menni et al., 2013).
Recent population studies of the human plasma glycome
revealed very large inter-individual differences in glycome com-
position (Kneževic´ et al., 2009). Interestingly, the variability in
composition of the glycome attached to immunoglobulin G (IgG;
Figure 1) was nearly three times larger than the variability of the
total plasma glycome (Pucic et al., 2011), indicating that the vari-
ation in concentration of different plasma proteins is blurring
the intricate regulation of glycosylation of an individual pro-
tein. Genome wide association studies (GWAS) performed in the
same populations revealed the similar situation. GWAS of the
plasma glycome in 2705 individuals identiﬁed three genetic loci
that associate with variation in glycosylation (Lauc et al., 2010),
while GWAS of the IgG glycome in 2247 individuals identiﬁed 16
genetic loci that associate with variations in the composition of
the IgG glycome (Lauc et al., 2013; Figure 2). This indicates that at
least three to four times more than currently estimated 750 genes
(Nairn et al., 2008), or at least 10% of the genome participates in
glycosylation.
GLYCANS PROVIDE HIGHER EUKARYOTES WITH UNIQUE
ADVANTAGES
Glycosylation, as the most complex epiproteomic modiﬁcation,
gives higher organisms some unique advantages. For example,
IgG is one of the most important weapons in our “arsenal,” which
enables us to successfully ﬁght with microorganisms, despite their
high mutation and reproduction rates. Evolution has invented
elaborate genetic mechanisms to create variability in the Fab
regions of immunoglobulins, but even more elaborate physiolog-
ical mechanism of the immune system are activated downstream
from the antigen-antibody recognition event (Marchalonis et al.,
2002). Since genes for the variable regions of immunoglobulins
are by large deﬁned before the ﬁrst encounter with their target,
polypeptide part of the antibody cannot be tuned to the type
of antigen it will recognize. However, different invaders (toxins,
viruses, bacteria, fungi, parasites) require activation of differ-
ent effector mechanisms, and this is where protein glycosylation
seems to be essential (Nimmerjahn and Ravetch, 2008; Mihai and
Nimmerjahn, 2012).
Each heavy chain of IgG carries a single covalently attached
bi-antennary N-glycan at the highly conserved asparagine 297
residue. The attached glycans are essential structural components
of the Fc region and minute changes in glycan composition can
signiﬁcantly change the conformation of the Fc region with dra-
matic consequences for IgG effector functions. For example, the
addition of a fucose residue to the ﬁrst N-acetylglucosamine in
the core of the glycan (core-fucose) modiﬁes the conformation
of the Fc region in a way to dramatically reduce its ability to
bind to FcγRIIIa (Iida et al., 2006; Masuda et al., 2007). FcγRIIIa
(CD16) is an activating Fc receptor expressed primarily on nat-
ural killer (NK) cells. Through binding to FcγRIIIa IgG initiates
antibody-dependent cellular cytotoxicity (ADCC) resulting in the
destruction of target cells. On average over 95% of circulating
IgGs are core-fucosylated (Pucic et al., 2011) and therefore contain
a “safety switch” which prevents them from eliciting potentially
destructive ADCC (Scanlan et al., 2008). The small fraction of
IgG molecules which lack core-fucose are over 100 times more
effective in initiating ADCC through FcγRIIIa binding and this
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FIGURE 1 | Inter-individual difference in composition of the glycome attached to immunoglobulin G (IgG) between six individuals.The term glycome
refers to the sum of all glycans that are attached to IgG molecules within an individual. The different (arbitrary) colors represent different N -glycan structures
that can be attached to IgG molecules within an individual.
FIGURE 2 | Genes that associate with variations in the composition of the IgG glycome. Arrows indicate the part of glycan structure with which particular
gene associates (Lauc et al., 2013). Blue square – N -Acetylglucosamine; green circle – mannose; yellow circle – galactose; red triangle – fucose; purple
diamond – sialic acid.
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also seems to be the primary mode of function of therapeutic
anti-cancer monoclonal antibodies (Shinkawa et al., 2003; Preith-
ner et al., 2006). Improper regulation of this process could lead
to either autoimmunity (too much ADCC) or cancer (inefﬁcient
ADCC).
Another structural alteration of the IgG glycan, the addi-
tion of sialic acid to the ends of glycans changes the function
of IgG and converts it from being pro-inﬂammatory into an
anti-inﬂammatory agent (Kaneko et al., 2006). Sialylation of
IgG was found to be essential for the function of intravenous
immunoglobulin (IVIG): its anti-inﬂammatory activity is con-
tained within the effector Fc portion, as Fc fragments alone
were found to be sufﬁcient to suppress inﬂammation (Debre
et al., 1993). It appears that Fc with sialylated glycans suppresses
inﬂammation through a novel TH2 pathway, which provides
an intrinsic mechanism for maintaining immune homeostasis
(Anthony et al., 2011). In addition to sialic acids, galactosyla-
tion was also shown to be important for the anti-inﬂammatory
activity of IgG (Karsten et al., 2012). Recently reported study by
Ackerman et al. (2013) represents just one of the examples how
variations in IgG glycosylation can provide new adaptive mech-
anism that allows ﬁght against pathogens and assure survival.
In this study it was shown that people called elite controllers,
who are able to control HIV infection and therefore do not get
sick, have glycosylation of HIV-speciﬁc antibody that promotes
strong pro-inﬂammatory response against the virus (Ackerman
et al., 2013). By delegating these tasks to glycans, evolution has
created a novel mechanism that enables creation of new struc-
tures (which determine antibody function) without the need to
alter genetic information. Other glycoproteins were not studied
in so much detail as IgG has been, but numerous other exam-
ples conﬁrm essential roles of alternative protein glycosylation in
many biological processes (Gornik et al., 2012). Among others,
binding of glycosylated ligands to selectins is the basis of lym-
phocyte homing (Walcheck et al., 1996; Sperandio et al., 2009)
and alternative glycosylation of Notch is essential for embry-
onic and adult development (Stanley, 2007). Notch protein is the
main actor in Notch signaling pathway that play role in proper
development of multicellular organisms. Notch is a transmem-
brane receptor composed of extracellular, transmembrane and
intracellular domains. Upon ligand binding intracellular domain
is cleaved and recruited into the nucleus to regulate expression
of target genes (Artavanis-Tsakonas et al., 1999). The glycosy-
lation of extracellular domain of Notch protein has impact on
ligand recognition and activation of Notch signaling. Four dif-
ferent types of glycans have been reported to be present on
Notch: N-glycans, O-fucose glycans, O-glucose glycans, and
O-GlcNAc glycans, but just two of them are known to sig-
niﬁcantly affect and modulate Notch activity: O-fucose glycans
and O-glucose glycans. The O-fucosylation of Notch extracellu-
lar domain is found to be important in ligand recognition and
binding (Stanley, 2007; Rana and Haltiwanger, 2011). Further
extension of O-fucose by the addition of N-acetylglucosamine,
in a reaction catalyzed by glycosyltransferase called Fringe, also
modulates Notch activity. Through the action of Fringe, Notch
signaling pathway can be induced or inhibited depending on the
type of ligand that interacts with Notch receptor (Hicks et al.,
2000). With respect to the role of Notch signaling in differenti-
ation of wide range of cell types it is evident that alterations in
pattern of glycosylation could provide mechanism by which dif-
ferent signals could be received through the same or homologous
signaling proteins. We can expect new insights into the impor-
tance of glycosylation on Notch signaling, starting with recently
reported study which has pointed out that Notch protein can
also carry O-linked GalNAc glycans with the role in formation
of body laterality (Boskovski et al., 2013). Another example of
role of glycosylationin signaling during development of multi-
cellular organisms is O-fucosylation of Crypto protein. Crypto
protein is one of the proteins involved in Nodal signaling path-
way and proper glycosylation of this protein is important for its
activity and binding properties (Schier and Shen, 2000; Yan et al.,
2002).
GLYCANS ENABLE DYNAMIC EPIGENETIC ADAPTATION
It is generally assumed that the appearance of self-replicating
nucleic acids (the ﬁrst revolution in evolution) provided the basis
for the development of early life. Nucleic acids then recruited
amino acids to create proteins, which are still the main effectors
of life at the cellular level (the second revolution). However, the
integration of different cells into a complex multicellular organ-
ism required an additional layer of complexity. Here we propose
that the invention of protein glycosylation (the third revolution)
through its inherent ability to create novel structures without the
need to alter genetic information enabled the development of
multicellular life in its present complexity.
The biggest evolutionary advantage that glycans confer to
higher eukaryotes is the ability to create new structures with-
out introducing changes into the precious genetic heritage (Lauc
and Zoldoš, 2010; Lauc et al., 2013). In principle all posttransla-
tional modiﬁcations enable this to some extent, but most of them
function as simple on/off molecular switches, while glycans rep-
resent signiﬁcant structural components contributing with up to
50% in mass (Pierce and Parsons, 1981) and even much more
to the molecular volume of many proteins (Bush et al., 1999).
The fact that so large parts of the molecule are not hardwired in
the genome provides a rapid and extensive epiproteomic adap-
tation mechanism. One example of role of glycosylation in the
process of adaptation is found to be important for function of
mammalian sperm cell and for the reproduction process itself.
Mammalian sperm cells are masked with sialylated sugars in order
to prevent recognition as foreign cells in the female reproductive
system. After successful adaptation of sperm cell to the new envi-
ronment, the removal of sialic acid residues from sperm surface
glycans is the necessary step in the process of sperm cell matura-
tion and the establishment of interaction between sperm and egg
cells (Ma et al., 2012). Another interesting example how glycosy-
lation of proteins can ensure adaptation and survival comes from
the kingdom of archaebacteria (Guan et al., 2012).
Epigenetic regulation of gene expression has been reported
to be important for protein glycosylation (Saldova et al., 2011;
Horvat et al., 2012, 2013; Zoldoš et al., 2012) and this could
explain the observed temporal stability of the glycome (Gornik
et al., 2009). Comparative studies of the glycome in different
organisms are rare, but they indicate higher rates of divergence in
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glycans than in proteins or DNA (Royle et al., 2008; Zielinska et al.,
2012; Adamczyk et al., 2014). Interactions established through
glycans are not restricted just to cell- cell interactions and com-
munication that could have played signiﬁcant role in the evolution
of multicellular life forms. Glycans also play signiﬁcant role in the
interaction between different organisms, including host-pathogen
interactions or interactions between symbionts. Effect of glyco-
sylation on the composition of the human intestinal microbiota
has been well examined (Koropatkin et al., 2012). Intestinal sym-
biotic bacteria are very important to humans as they help in food
digestion, produce some vitamins and provide protection against
pathogenic bacteria. In return, symbiotic bacteria use host gly-
can molecules as receptors for colonization of intestine and, also,
both host and dietary glycans serve as energy source for symbiotic
bacteria. It is reported that individuals who don’t secrete blood
group glycans into the intestinal mucosa have reduced number
and diversity of probiotic bacteria in the intestine (Wacklin et al.,
2011). Except for food, symbiotic bacteria also use sugars that are
highly abundant in intestine for glycosylation of their surface in
order to escape the human immune system (Coyne et al., 2005).
Furthermore, digestion of sugars by symbiotic bacteria enables
activation of signaling system that control pathogenicity of some
non-symbiotic bacteria (Pacheco et al., 2012). Based on these facts,
it can be safely assumed that glycans play important role in evo-
lution of symbiotic relationship between humans and intestinal
bacteria.
In some biological systems, like for example AB0 blood groups,
glycans act as simple molecular switches that introduce inter-
individual variability of cellular surfaces. In other systems, like
immunoglobulin glycosylation, they enable new physiological
functions, which could not be performed without this complex
posttranslational tool. Glycosylation is particularly complex in
human brain, but currently available technologies do not allow
detailed study of this highly intricate system. Since all eukaryotic
cells are heavily glycosylated (at signiﬁcant metabolic cost) and
elaboratemechanisms that regulate glycosylation are being discov-
ered, we propose that the invention of glycosylation was the third
large revolution in evolution, which enabled the development of
complex multicellular organisms.
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